@ha.store123: Giường gấp gọn #giuonggapgon #viralvideo #xuhuongtiktok

Thu Hà

Open In TikTok:

Region: VN

Thursday 20 August 2026 06:59:10 GMT

329

1

0

1

Music

Download

No Watermark .mp4 (3.79MB) No Watermark(HD) .mp4 (3.79MB) Watermark .mp4 (3.9MB) Music .mp3

Comments

There are no more comments for this video.

To see more videos from user @ha.store123, please go to the Tikwm homepage.

Other Videos

あなたはオッサンですか？ #chatGPT #ai育成 #fpy #こんびにこ #タゴサク構文？

あなたはオッサンですか？ #chatGPT #ai育成 #fpy #こんびにこ #タゴサク構文？

👩‍🦰

Wedding Vlog as a wedding guest! #weddingvlog #weddingguest #wedding2026

Wedding Vlog as a wedding guest! #weddingvlog #weddingguest #wedding2026

@vinhdzvcl7 #thếvinh

@vinhdzvcl7 #thếvinh

🚨 Doctors are still waiting years to protect your heart and kidneys. The old rule was lifestyle first, metformin second, and cardioprotective drugs only after complications showed up. The 2026 ADA guidelines say that delay costs organs. But the data says otherwise. 🩺 I am a cardiologist. I do not wait for complications to start these drugs anymore. 💓 Here is what the science actually says. ✅ SGLT2 inhibitors cut cardiovascular death by 34% in high risk patients. ✅ GLP-1 receptor agonists reduced major cardiac events by 26% in the LEADER trial. ✅ Early SGLT2 use cut kidney failure risk by 40%. That is not glucose control. That is organ protection. 🫀 The new standard is three pillars. Lifestyle, metformin, and cardioprotective therapy, started together, not sequentially. For decades we treated these drugs as a last resort. The 2026 guidelines treat them as day one therapy, because the heart and kidneys start taking damage long before your A1C tells the story. ❤️ Bottom line: This is not about waiting for failure to justify treatment. The evidence is strong enough to act early, not eventually. If you have diabetes, ask your doctor about SGLT2 and GLP-1 therapy now, not after your first heart attack or your first dialysis referral. The question is no longer if you need them. It is why you are still waiting. Full breakdown of the new ADA guidelines on my blog: https://dralo.net/blog/diabetes-guidelines Dr. Alo, America’s Cardiologist #Cardiology #HeartDisease #HeartHealth #Diabetes #SGLT2 #GLP1 #CardiovascularHealth #PreventiveCardiology #MetabolicHealth #KidneyHealth

🚨 Doctors are still waiting years to protect your heart and kidneys. The old rule was lifestyle first, metformin second, and cardioprotective drugs only after complications showed up. The 2026 ADA guidelines say that delay costs organs. But the data says otherwise. 🩺 I am a cardiologist. I do not wait for complications to start these drugs anymore. 💓 Here is what the science actually says. ✅ SGLT2 inhibitors cut cardiovascular death by 34% in high risk patients. ✅ GLP-1 receptor agonists reduced major cardiac events by 26% in the LEADER trial. ✅ Early SGLT2 use cut kidney failure risk by 40%. That is not glucose control. That is organ protection. 🫀 The new standard is three pillars. Lifestyle, metformin, and cardioprotective therapy, started together, not sequentially. For decades we treated these drugs as a last resort. The 2026 guidelines treat them as day one therapy, because the heart and kidneys start taking damage long before your A1C tells the story. ❤️ Bottom line: This is not about waiting for failure to justify treatment. The evidence is strong enough to act early, not eventually. If you have diabetes, ask your doctor about SGLT2 and GLP-1 therapy now, not after your first heart attack or your first dialysis referral. The question is no longer if you need them. It is why you are still waiting. Full breakdown of the new ADA guidelines on my blog: https://dralo.net/blog/diabetes-guidelines Dr. Alo, America’s Cardiologist #Cardiology #HeartDisease #HeartHealth #Diabetes #SGLT2 #GLP1 #CardiovascularHealth #PreventiveCardiology #MetabolicHealth #KidneyHealth

#CapCut 🦋🦋🦋🦋🦋🦋

#CapCut 🦋🦋🦋🦋🦋🦋

About

Robot
API

Legal

Privacy Policy